<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03636542</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00003353</org_study_id>
    <nct_id>NCT03636542</nct_id>
  </id_info>
  <brief_title>Evaluation of Diaphragm Movement After an Interscalene Block</brief_title>
  <official_title>Evaluation of Diaphragm Movement After an Interscalene Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the movement of the diaphragm after an interscalene
      block with liposome bupivacaine (LB) compared to interscalene block (IB) with bupivacaine.
      This study will evaluate if there is a possible prolonged phrenic nerve paralysis when using
      liposome bupivacaine in an interscalene block, using ultrasound.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be run concurrently with two other studies comparing bupivacaine to Liposomal
      Bupivacaine in shoulder surgeries. We will use already randomized patients for our
      randomization process. For this study in particular we will use an ultrasound machine to scan
      the diaphragm of any patient who had an Interscalene Block for Total Shoulder Arthroplasy or
      Rotator Cuff Repair. Patients are to be scanned in an upright sitting position and scanned
      from a low intercostal or subcostal approach using the liver or spleen as an acoustic window.
      M Mode will be applied and the range of diaphragmatic movement from the resting expiratory
      position to deep inspiration (sigh test) will be recorded as was the range of diaphragmatic
      movement from resting expiratory position when quickly inspiring through the nose (sniff
      test). The blocks will be done regardless of the study as they are standard of care for pain
      control. The only intervention is ultrasound examination of the patient's diaphragm at
      baseline, 3 hours post block in recovery room and on post-operative day 1, and basic
      spirometry to record FEV1 and FVC via a portable spirometer at the same time points. If
      patients did stay in hospital on postoperative day 2 we would also evaluate their diaphragm
      function.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diaphragm excursion with sigh</measure>
    <time_frame>change from baseline to 24 hours after block</time_frame>
    <description>Evaluation of diaphragm excursion (movement in cm) from rest to sigh in a sitting position.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diaphragm excursion with quick inspiratory breath</measure>
    <time_frame>change from baseline to 24 hours after block</time_frame>
    <description>Evaluation of diaphragm excursion (movement in cm) from rest to a quick inspiratory breath.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced expiratory volume in 1 second (FEV1)</measure>
    <time_frame>change from baseline to 24 hours after block</time_frame>
    <description>Evaluation of FEV1 via spirometry.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced vital capacity (FVC)</measure>
    <time_frame>change from baseline to 24 hours after block</time_frame>
    <description>Evaluation of FVC via spirometry.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FEV1/FVC ratio</measure>
    <time_frame>change from baseline to 24 hours after block</time_frame>
    <description>Evaluation of FEV1/FVC ratio via spirometry.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Phrenic Nerve Paralysis</condition>
  <arm_group>
    <arm_group_label>liposomal bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>These patients receive an interscalene block with liposomal bupivacaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>These patients receive an interscalene block with bupivacaine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>liposomal bupivacaine</intervention_name>
    <description>Experimental</description>
    <arm_group_label>liposomal bupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine</intervention_name>
    <description>Active comparator</description>
    <arm_group_label>bupivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients age 18 years and older who are scheduled for shoulder surgery with
             interscalene block and remain in the hospital for more than 24 hours that are being
             randomized into a bupivacaine versus liposomal bupivacaine interscalene block study.

        Exclusion Criteria:

          -  Non English speaking patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason habeck, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jason Habeck, MD</last_name>
    <phone>612-624-9990</phone>
    <email>habe0073@umn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Melissa Cohen</last_name>
    <phone>612-624-9990</phone>
    <email>Cohen045@umn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Univeristy of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Cohen</last_name>
      <phone>612-625-7116</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>July 20, 2018</study_first_submitted>
  <study_first_submitted_qc>August 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2018</study_first_posted>
  <last_update_submitted>January 21, 2020</last_update_submitted>
  <last_update_submitted_qc>January 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paralysis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

